Rizatriptan benzoate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 62135-998
  • Package NDC 62135-998-17
  • Application number ANDA078739
  • SPL ID 5b65c71e-7c93-7d74-e063-6294a90a0597
  • SPL set ID faf3bc1d-8818-47b0-8ad1-80bfbf40ab78
  • UNII WR978S7QHH
  • RxCUI 312837
  • RxCUI 312839

What the source publishes

Labeler
Chartwell RX, LLC
Active ingredients
Rizatriptan Benzoate
Form
TABLET, ORALLY DISINTEGRATING
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:62135-998_5b65c71e-7c93-7d74-e063-6294a90a0597
{
  "name": "Rizatriptan benzoate",
  "splId": "5b65c71e-7c93-7d74-e063-6294a90a0597",
  "labels": [
    {
      "setId": "faf3bc1d-8818-47b0-8ad1-80bfbf40ab78",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=faf3bc1d-8818-47b0-8ad1-80bfbf40ab78",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=faf3bc1d-8818-47b0-8ad1-80bfbf40ab78"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Chartwell RX, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "18 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62135-998-17)",
      "package_ndc": "62135-998-17",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260826"
    }
  ],
  "productId": "62135-998_5b65c71e-7c93-7d74-e063-6294a90a0597",
  "useDomain": "unknown",
  "dosageForm": "TABLET, ORALLY DISINTEGRATING",
  "productNdc": "62135-998",
  "deaSchedule": null,
  "genericName": "Rizatriptan Benzoate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "RIZATRIPTAN BENZOATE",
      "strength": "5 mg/1"
    }
  ],
  "applicationNumber": "ANDA078739",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20130701",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0362135999179",
      "0362135998172"
    ],
    "unii": [
      "WR978S7QHH"
    ],
    "rxcui": [
      "312837",
      "312839"
    ],
    "spl_set_id": [
      "faf3bc1d-8818-47b0-8ad1-80bfbf40ab78"
    ],
    "manufacturer_name": [
      "Chartwell RX, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:62135-998_5b65c71e-7c93-7d74-e063-6294a90a0597"